Literature DB >> 8519683

bcl-2 inhibits wild-type p53-triggered apoptosis but not G1 cell cycle arrest and transactivation of WAF1 and bax.

Y Wang1, I Okan, L Szekely, G Klein, K G Wiman.   

Abstract

We have earlier shown that wild-type (wt) p53 expressed from a temperature-sensitive construct (ts p53) triggers apoptosis in the v-myc retrovirus-induced, p53-negative T-cell lymphoma line J3D (Y. Wang et al., Cell Growth & Differ., 4: 467-473, 1993). We also found that constitutive bcl-2 expression inhibits wt p53-triggered apoptosis in these cells (Y. Wang et al., Oncogene, 8: 3427-3431, 1993). Here we demonstrate that more than 90% of the ts p53-transfected J3D cells were arrested in G1 at 18 h after induction of wt p53 expression by temperature shift to 32 degrees C. At this time, at least 80% of the cells remained viable. After 30 h at 32 degrees C, around 50% of the cells had died by apoptosis, while most of the remaining cells were still alive in G1, indicating that p53-induced apoptosis occurred following G1 arrest. The G1 cell cycle arrest at 18 h after temperature shift to 32 degrees C was reversible, as shown by the fact that the cells readily resumed exponential growth following temperature shift back to 37 degrees C, although viability dropped from around 80 to 65%. Expression of both WAF1 and bax mRNA was induced by wt p53 in both the ts p53 and ts p53/bcl-2 transfected cells. The kinetics of G1 cell cycle arrest at 32 degrees C was similar in both the ts p53 and the ts p53/bcl-2 double transfectants.(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Year:  1995        PMID: 8519683

Source DB:  PubMed          Journal:  Cell Growth Differ        ISSN: 1044-9523


  6 in total

1.  Inosine-5'-monophosphate dehydrogenase is a rate-determining factor for p53-dependent growth regulation.

Authors:  Y Liu; S A Bohn; J L Sherley
Journal:  Mol Biol Cell       Date:  1998-01       Impact factor: 4.138

Review 2.  The p53 tumour suppressor gene: a mediator of a G1 growth arrest and of apoptosis.

Authors:  E Yonish-Rouach
Journal:  Experientia       Date:  1996-10-31

Review 3.  Curcumin: A review of anti-cancer properties and therapeutic activity in head and neck squamous cell carcinoma.

Authors:  Reason Wilken; Mysore S Veena; Marilene B Wang; Eri S Srivatsan
Journal:  Mol Cancer       Date:  2011-02-07       Impact factor: 27.401

Review 4.  Cancer of Unknown Primary Site: Real Entity or Misdiagnosed Disease?

Authors:  Alaa T Alshareeda; Batla S Al-Sowayan; Reem R Alkharji; Sahar M Aldosari; Abdullah M Al Subayyil; Ayidah Alghuwainem
Journal:  J Cancer       Date:  2020-04-06       Impact factor: 4.207

5.  Gene Expression upon Proliferation and Differentiation of Hematopoietic Cells with Ph Chromosome ex vivo.

Authors:  N I Grineva; E A Duchovenskay; A M Timofeev; T V Akhlynina; L P Gerasimova; T V Borovkova; D A Schmarov; N G Sarycheva; N M Naydenova; A R Gavrichkova; L Y Kolosova; T I Kolosheynova; L G Kovaleva
Journal:  Acta Naturae       Date:  2012-07       Impact factor: 1.845

6.  De Novo transcriptome assembly (NGS) of Curcuma longa L. rhizome reveals novel transcripts related to anticancer and antimalarial terpenoids.

Authors:  Ramasamy S Annadurai; Ramprasad Neethiraj; Vasanthan Jayakumar; Anand C Damodaran; Sudha Narayana Rao; Mohan A V S K Katta; Sreeja Gopinathan; Santosh Prasad Sarma; Vanitha Senthilkumar; Vidya Niranjan; Ashok Gopinath; Raja C Mugasimangalam
Journal:  PLoS One       Date:  2013-02-28       Impact factor: 3.240

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.